Mengdan Li

机构：Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, Liaoning Cancer Hospital & Institute, Chinese Academy of Governance, Chongqing Medical University · ORCID：0009-0006-9235-8924

发表论文 48 篇 · 总被引 470 次 · h-index 11

代表论文

• Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m6A-YTHDF1-dependent manner (2024 · International Journal of Biological Sciences · 被引 21)
• Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women (2024 · BMC Women s Health · 被引 20)
• Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide–Drug Conjugates (2024 · Journal of Medicinal Chemistry · 被引 18)
• The value of a neural network based on multi-scale feature fusion to ultrasound images for the differentiation in thyroid follicular neoplasms (2024 · BMC Medical Imaging · 被引 14)
• Engineered Nanocatalyst‐Enabled Cheolesterol Depletion for Enhanced Tumor Piezocatalytic Therapy (2025 · Advanced Science · 被引 7)
• Cancer literacy differences of basic knowledge, prevention, early detection, treatment and recovery: a cross-sectional study of urban and rural residents in Northeast China (2024 · Frontiers in Public Health · 被引 7)